Development of Protecting Groups for Prodrug-Type Oligonucleotide Medicines

DOI Web Site Web Site PubMed 被引用文献3件 参考文献53件 オープンアクセス
  • Saneyoshi Hisao
    Department of Material and Life Chemistry, Faculty of Engineering, Kanagawa University
  • Ono Akira
    Department of Material and Life Chemistry, Faculty of Engineering, Kanagawa University

この論文をさがす

説明

<p>In recent years, nucleic acid-based drug therapeutics have gained considerable attention for their potential in the treatment of various diseases. However, their therapeutic value is greatly hindered by the challenge of delivering them into cells. One possible strategy to improve cellular uptake is the use of “prodrug-type oligonucleotide medicine” in which negatively charged phosphodiester moieties are masked by bio-labile protecting groups. In this review, we describe our recent studies related to bio-labile protecting groups for phosphodiester moieties in the development of prodrug-type oligonucleotide medicines.</p>

収録刊行物

被引用文献 (3)*注記

もっと見る

参考文献 (53)*注記

もっと見る

関連プロジェクト

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ